Melissa Hamilton

980 total citations
35 papers, 715 citations indexed

About

Melissa Hamilton is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Melissa Hamilton has authored 35 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 11 papers in Economics and Econometrics. Recurrent topics in Melissa Hamilton's work include Atrial Fibrillation Management and Outcomes (18 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Melissa Hamilton is often cited by papers focused on Atrial Fibrillation Management and Outcomes (18 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Melissa Hamilton collaborates with scholars based in United States, United Kingdom and Germany. Melissa Hamilton's co-authors include Xianying Pan, Jack Mardekian, Xuemei Luo, Keith Friend, Kiran Gupta, Gregory Y.H. Lip, Allison Keshishian, Anagha Nadkarni, Xiaoyan Li and Onur Başer and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Melissa Hamilton

34 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Hamilton United States 13 506 289 87 85 84 35 715
Anna‐Katharina Meinecke Germany 13 257 0.5× 144 0.5× 38 0.4× 113 1.3× 46 0.5× 19 494
Dinara Makenbaeva United States 13 326 0.6× 134 0.5× 25 0.3× 43 0.5× 84 1.0× 46 606
Mika Skeppholm Sweden 15 584 1.2× 270 0.9× 43 0.5× 94 1.1× 17 0.2× 23 728
Daniel Eriksson Germany 13 293 0.6× 163 0.6× 30 0.3× 73 0.9× 57 0.7× 38 539
Sridhar Kamath United Kingdom 6 301 0.6× 117 0.4× 39 0.4× 68 0.8× 24 0.3× 10 418
Cecilia Guillermo Uruguay 9 356 0.7× 252 0.9× 27 0.3× 39 0.5× 12 0.1× 32 554
M. Iotti Italy 7 535 1.1× 706 2.4× 41 0.5× 51 0.6× 29 0.3× 9 834
Paula F. Ypma Netherlands 15 162 0.3× 121 0.4× 34 0.4× 63 0.7× 21 0.3× 57 770
Habeeb Majeed Canada 11 104 0.2× 129 0.4× 88 1.0× 22 0.3× 26 0.3× 20 459
Issa Alesh United States 9 367 0.7× 130 0.4× 41 0.5× 73 0.9× 128 1.5× 21 982

Countries citing papers authored by Melissa Hamilton

Since Specialization
Citations

This map shows the geographic impact of Melissa Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Hamilton more than expected).

Fields of papers citing papers by Melissa Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Hamilton. The network helps show where Melissa Hamilton may publish in the future.

Co-authorship network of co-authors of Melissa Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Hamilton. A scholar is included among the top collaborators of Melissa Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Hamilton. Melissa Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schadendorf, Dirk, Hussein A. Tawbi, Evan J. Lipson, et al.. (2023). Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial. European Journal of Cancer. 187. 164–173. 9 indexed citations
2.
3.
Baker, Timothy, Helen M. Johnson, Srividya Kotapati, et al.. (2022). Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067. PharmacoEconomics - Open. 6(5). 697–710. 6 indexed citations
4.
Cella, David, Toni K. Choueiri, Melissa Hamilton, et al.. (2022). Health-related quality of life (HRQoL) in previously untreated patients with advanced renal cell carcinoma (aRCC) in CheckMate 214: Five-year follow-up results.. Journal of Clinical Oncology. 40(6_suppl). 307–307.
5.
Deitelzweig, Steve, Allison Keshishian, Xiaoyan Li, et al.. (2018). COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE. Journal of the American College of Cardiology. 71(11). A275–A275. 3 indexed citations
6.
Lip, Gregory Y.H., Allison Keshishian, Xiaoyan Li, et al.. (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients. Stroke. 49(12). 2933–2944. 225 indexed citations
7.
Weycker, Derek, Xiaoyan Li, Gail Wygant, et al.. (2018). SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM. Journal of the American College of Cardiology. 71(11). A1953–A1953. 1 indexed citations
8.
Lópes, Renato D., Jan Steffel, Manuela Di Fusco, et al.. (2018). Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. The American Journal of Medicine. 131(9). 1075–1085.e4. 14 indexed citations
9.
Deitelzweig, Steve, Allison Keshishian, Xiaoyan Li, et al.. (2017). Abstract 16462: Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases. Circulation. 1 indexed citations
10.
11.
Li, Xiaoyan, Steve Deitelzweig, Allison Keshishian, et al.. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice. Thrombosis and Haemostasis. 117(6). 1072–1082. 122 indexed citations
12.
13.
Kachroo, Sumesh, Melissa Hamilton, Xianchen Liu, et al.. (2016). Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation.. PubMed. 22(1). e1–8. 31 indexed citations
14.
Lanitis, Tereza, et al.. (2016). Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Clinical Therapeutics. 38(3). 478–493.e16. 14 indexed citations
15.
16.
Lee, Theodore, Cristina Masseria, Andrei Breazna, et al.. (2016). HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL. Journal of the American College of Cardiology. 67(13). 2256–2256. 1 indexed citations
17.
Biskupiak, Joseph, Sameer R. Ghate, Melissa Hamilton, et al.. (2014). ORAL ANTICOAGULANT (OAC) UTILIZATION IN ATRIAL FIBRILLATION AFTER THE INTRODUCTION OF NOVEL ORAL ANTICOAGULANTS. Journal of the American College of Cardiology. 63(12). A326–A326. 1 indexed citations
18.
Moore, Peter, et al.. (2014). Seven Years Experience of a Nurse-Led Elective Cardioversion Service in a Tertiary Referral Centre: An Observational Study. Heart Lung and Circulation. 23(6). 555–559. 10 indexed citations
19.
Pan, Xianying, Teresa A. Simon, Melissa Hamilton, & Andreas Kuznik. (2014). Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States. Journal of Thrombosis and Thrombolysis. 39(4). 508–515. 13 indexed citations
20.
Başer, Onur, Xianchen Liu, Hemant Phatak, et al.. (2013). Venous Thromboembolism Prophylaxis and Clinical Consequences in Medically Ill Patients. American Journal of Therapeutics. 20(2). 132–142. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna‐Katharina Meinecke Breakdown of academic impact, for papers by Dinara Makenbaeva Breakdown of academic impact, for papers by Mika Skeppholm Breakdown of academic impact, for papers by Daniel Eriksson Breakdown of academic impact, for papers by Sridhar Kamath Breakdown of academic impact, for papers by Cecilia Guillermo Breakdown of academic impact, for papers by M. Iotti Breakdown of academic impact, for papers by Paula F. Ypma Breakdown of academic impact, for papers by Habeeb Majeed Breakdown of academic impact, for papers by Issa Alesh
Rankless by CCL
2026